Stock listing
A407YS Stock Price, News, Filings & Events — Cartesian Therapeutics, Inc.
Selected listing: A407YS · LSX · EUR · DE
This page tracks Cartesian Therapeutics, Inc.'s A407YS:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A407YS:LSX. A407YS:LSX is the stock-level entry point for investors researching Cartesian Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A407YS:LSX
- Asset type
- Stock
- Market cap
- $247.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Cartesian Therapeutics, Inc. A407YS:LSX stock context
This page tracks Cartesian Therapeutics, Inc.'s A407YS:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A407YS:LSX. A407YS:LSX is the stock-level entry point for investors researching Cartesian Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Cartesian Therapeutics, Inc.
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Pla...
June 9, 2026
Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phas...
May 26, 2026
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 12, 2026
Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
April 30, 2026
Cartesian Therapeutics, Inc. earnings calls
Selecta Biosciences, Inc. (SELB) Q2 2023 Earnings Call
August 17, 2023 · Replay with transcript and chapters
Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call
May 4, 2023 · Replay with transcript and chapters
Selecta Biosciences, Inc. (SELB) Q3 2022 Earnings Call
November 3, 2022 · Replay with transcript and chapters
Selecta Biosciences, Inc. (SELB) Q2 2022 Earnings Call
August 4, 2022 · Replay with transcript and chapters
Selecta Biosciences, Inc. (SELB) Q1 2022 Earnings Call
May 5, 2022 · Replay with transcript and chapters
Selecta Biosciences, Inc. (SELB) Q3 2021 Earnings Call
November 9, 2021 · Replay with transcript and chapters
Research Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A407YS:LSX.
Cartesian Therapeutics, Inc. company profile
View the public company page for Cartesian Therapeutics, Inc. on 6ix.
Cartesian Therapeutics, Inc. news
Read company news and market updates connected to Cartesian Therapeutics, Inc..
Cartesian Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Cartesian Therapeutics, Inc..
Alternate listings
RNAC:NASDAQ
US · USD
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.
A407YS:LS
DE · EUR
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.
RNAC:BOATS
US · USD
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.
1S70:GETTEX
DE · EUR
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.
1S70:FWB
DE · EUR
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.
1S70:MUN
DE · EUR
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.
1S70:SWB
DE · EUR
Alternate listing for Cartesian Therapeutics, Inc.; the primary context on this page is A407YS:LSX.